N-terminal pro B-type natriuretic peptide (NT-proBNP): a possible surrogate of biological age in the elderly people

被引:0
|
作者
Antonio Muscari
Giampaolo Bianchi
Paola Forti
Donatella Magalotti
Paolo Pandolfi
Marco Zoli
机构
[1] University of Bologna-S.Orsola-Malpighi Hospital,Department of Medical and Surgical Sciences
[2] S.Orsola-Malpighi Hospital,Medical Department of Continuity of Care and Disability
[3] AUSL Bologna,Epidemiological and Health Promotion Unit, Department of Public Health
来源
GeroScience | 2021年 / 43卷
关键词
NT-proBNP; Mortality; Biological age; Epidemiological studies;
D O I
暂无
中图分类号
学科分类号
摘要
NT-proB-type natriuretic peptide (NT-proBNP) increases with age and is associated with all-cause mortality. With this study, we assessed its possible utilization as a marker of biological age in comparison with other variables. The study included 1079 non-institutionalized elderly subjects (mean age 72.8 ± 5.5 years, 561 women). Baseline measurements were performed of serum NT-proBNP and of some laboratory variables previously utilized to estimate biological age (creatinine, albumin, C-reactive protein, cholesterol, blood glucose, leukocytes, lymphocytes, hemoglobin, mean cell volume). During 7 years of follow-up, 114 all-cause deaths occurred. The logarithm of NT-proBNP was the most age-related parameter (r = 0.35, P < 0.0001). Its relationship with mortality, according to Cox regression and ROC curve (AUC = 0.707, 95% CI 0.654–0.759), was stronger than that of all other variables, including age. In multivariate analysis, only NT-proBNP and age remained independently associated with mortality. The regression lines between age and NT-proBNP (pg/ml) allowed a separate estimation of biological age (“proBNPage”) for men (= [log(NT-proBNP) + 1.2068]/0.0827) and for women (= [log(NT-proBNP) − 1.5258]/0.0478). The hazard ratio of all-cause mortality for the fifth quintile of proBNP age (≥ 85 years) compared with the first quintile (< 61 years) was 7.9 (95% CI 3.6–17.5). Similarly, the difference between pro-BNPage and chronological age was associated with a hazard ratio of 3.5 in the fifth quintile (95% CI 1.9–6.4) and was associated with disease count (P for trend = 0.0002). In conclusion, NT-proBNP was the best indicator of biological age, which can be estimated by simple formulas and might be used for prognostic purposes or as a surrogate end point in epidemiological and intervention studies.
引用
收藏
页码:845 / 857
页数:12
相关论文
共 50 条
  • [21] B-type natriuretic peptide (NT-proBNP) and thyroid function: study in elderly subjects
    S Mastroianni
    A Grembiale
    E Succurro
    M Lugarà
    F Iorio
    V Caruso
    S Cufone
    E Pedace
    M Ruffo
    C Cloro
    F Arturi
    BMC Geriatrics, 10 (Suppl 1)
  • [22] Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure
    Fabian Knebel
    Stephan Eddicks
    Ingolf Schimke
    Michael Bierbaum
    Sebastian Schattke
    Mark Beling
    Vanessa Raab
    Gert Baumann
    Adrian C Borges
    Cardiovascular Ultrasound, 6
  • [23] Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure
    Knebel, Fabian
    Eddicks, Stephan
    Schimke, Ingolf
    Bierbaum, Michael
    Schattke, Sebastian
    Beling, Mark
    Raab, Vanessa
    Baumann, Gert
    Borges, Adrian C.
    CARDIOVASCULAR ULTRASOUND, 2008, 6 (1)
  • [24] Comparison of the cardiac markers B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide
    Buchner, Stefan
    Jungbauer, Carsten
    Birner, Christoph
    Debl, Kurt
    Riegger, Guenter A.
    Luchner, Andreas
    BIOMARKERS IN MEDICINE, 2009, 3 (05) : 465 - 481
  • [25] Genetic association analysis of the cardiovascular biomarker: N-terminal fragment of pro-B-type natriuretic peptide (NT-proBNP)
    Yang, Yuan
    Zmuda, Joseph M.
    Wojczynski, Mary K.
    Thyagarajan, Bharat
    Christensen, Kaare
    Cvejkus, Ryan K.
    Kuipers, Allison L.
    PLOS ONE, 2021, 16 (03):
  • [26] N-terminal PRO-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART
    Berg, T.
    Zdunck, D.
    Stalke, J.
    Dupke, S.
    Baumgarten, A.
    Carganico, A.
    Hess, G.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2007, 12 (04) : 152 - 160
  • [27] Evaluation of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) assay in clinical practice: comparison methods
    Mazza, A. Alberto
    Stoppa, A.
    Bedendo, E.
    Zuin, M.
    Schiavon, L.
    Molinari, L.
    Napoli, E.
    Pontesilli, G. M.
    Camerotto, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 174 - 174
  • [28] NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke Results From the BiomarCaRE Consortium
    Di Castelnuovo, Augusto
    Veronesi, Giovanni
    Costanzo, Simona
    Zeller, Tanja
    Schnabel, Renate B.
    de Curtis, Amalia
    Salomaa, Veikko
    Borchini, Rossana
    Ferrario, Marco
    Giampaoli, Simona
    Kee, Frank
    Soderberg, Stefan
    Niiranen, Teemu
    Kuulasmaa, Kari
    de Gaetano, Giovanni
    Donati, Maria Benedetta
    Blankenberg, Stefan
    Iacoviello, Licia
    STROKE, 2019, 50 (03) : 610 - 617
  • [29] Weight Change and Change in N-Terminal pro-Brain Natriuretic Peptide (NT-proBNP)
    Lazo, Mariana
    Ndumele, Chiadi
    Coresh, Josef
    Vaidya, Dhanajay
    Ballantyne, Christie M.
    Selvin, Elizabeth
    DIABETES, 2014, 63 : A351 - A351
  • [30] Weight Variation and Change in N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
    Da Silva, Mariana Sbaraini
    Lazo, Mariana
    Daya, Natalie R.
    Tang, Olive
    Ballantyne, Christie M.
    Ndumele, Chiadi E.
    Selvin, Elizabeth
    CIRCULATION, 2020, 141